HM Payson & Co. Has $33.45 Million Stock Holdings in Danaher Corporation $DHR

HM Payson & Co. increased its position in shares of Danaher Corporation (NYSE:DHRFree Report) by 12.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 168,704 shares of the conglomerate’s stock after purchasing an additional 18,447 shares during the quarter. HM Payson & Co.’s holdings in Danaher were worth $33,447,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in DHR. DRW Securities LLC boosted its holdings in shares of Danaher by 52.0% in the 1st quarter. DRW Securities LLC now owns 1,339 shares of the conglomerate’s stock worth $274,000 after acquiring an additional 458 shares in the last quarter. Saudi Central Bank bought a new position in Danaher in the 1st quarter valued at $52,000. Quarry LP increased its stake in shares of Danaher by 3,848.7% in the first quarter. Quarry LP now owns 1,540 shares of the conglomerate’s stock valued at $316,000 after buying an additional 1,501 shares in the last quarter. Armistice Capital LLC bought a new stake in Danaher during the 1st quarter worth about $16,603,000. Finally, ICW Investment Advisors LLC lifted its position in shares of Danaher by 2.9% during the first quarter. ICW Investment Advisors LLC now owns 5,126 shares of the conglomerate’s stock worth $1,051,000 after purchasing an additional 144 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the sale, the senior vice president owned 2,625 shares of the company’s stock, valued at $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Teri List sold 3,298 shares of the firm’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the sale, the director owned 20,762 shares in the company, valued at approximately $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 30,248 shares of company stock worth $6,609,663 over the last ninety days. 11.20% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

DHR has been the subject of several research reports. Jefferies Financial Group lifted their target price on Danaher from $245.00 to $255.00 and gave the company a “buy” rating in a research note on Wednesday, December 17th. Evercore ISI lifted their price objective on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Rothschild Redb downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. HSBC raised their target price on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research note on Monday, December 1st. Finally, The Goldman Sachs Group began coverage on shares of Danaher in a research note on Tuesday, December 9th. They set a “buy” rating and a $265.00 price target for the company. Twenty-one equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $248.25.

Read Our Latest Stock Analysis on DHR

Danaher Stock Performance

Shares of NYSE:DHR opened at $230.52 on Monday. The firm’s 50 day simple moving average is $222.66 and its 200 day simple moving average is $208.22. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $258.23. The company has a market capitalization of $162.83 billion, a price-to-earnings ratio of 47.53, a P/E/G ratio of 4.45 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10.

Danaher (NYSE:DHRGet Free Report) last issued its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.71 earnings per share. As a group, sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.32 per share. The ex-dividend date is Friday, December 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s payout ratio is currently 26.39%.

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.